Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robots and eye-tracking reveal hidden stroke recovery clues

NCT ID NCT07254949

Knowledge-focused Sponsor: Dr. Sean Dukelow Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study uses robots and eye-tracking to measure how vision and body awareness (proprioception) affect arm movement after a stroke. Researchers will follow 425 stroke survivors for six months to understand how these senses recover and how brain damage relates to recovery. The goal is to improve future treatments, not to test a new therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 425 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2026

An estimate. Start dates often move.

Expected to finish

Jun 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

425 participants will be recruited for this study (225 stroke participants and 200 matched control participants who have not experienced a stroke). All participant will be aged 18 or older.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria for stroke participants: * 18 years of age or older * First clinical diagnosis of stroke * No recent muscle skeletal injuries to the arms, neck, or back * No history of other neurological disease/injury (Ie. MS, Parkinson's, Brain Tumour, etc.) * Corrected vision 20/50 or better * Able to follow multi-step commands. * Living independently prior to stroke * Can consent to participate in research Inclusion criteria for control participants: * 18 years of age or older * No history stroke, or Trans Ischemic Attack (TIA) * No recent muscle skeletal injures to the arms, neck, or back * No history of other neurological disease/ injury (Ie. MS, Parkinson's, Brain Tumour, etc) * No pre-stroke history of eye movement disorders * Corrected vision 20/50 or better * Able to follow multi-step commands * Can consent to participate in research Exclusion Criteria: * Prior history of stroke/significant neurologic problem (e.g. Parkinson's) * Symptomatic medical conditions that would interfere with participation (e.g. uncontrolled angina) * Contraindications to Magnetic Resonance Imaging (MRI) * Pre-stroke history of visual field/oculomotor abnormalities.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Control condition are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Control condition Stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Carewest Dr. Vernon Fanning Centre

    Calgary, Alberta, Canada

  • Foothills Medical Centre

    Calgary, Alberta, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.